Bismuth based nanomaterials: Design, synthesis and applications in tumor synergistic therapy.

IF 5.6 2区 医学 Q1 BIOPHYSICS
Qiupeng Zhang, Jie Tu, Yuqin Jiang, Huihui Wang, Weixian Xue, Chunyao Dong, Ruizhuo Ouyang, Yuqing Miao
{"title":"Bismuth based nanomaterials: Design, synthesis and applications in tumor synergistic therapy.","authors":"Qiupeng Zhang, Jie Tu, Yuqin Jiang, Huihui Wang, Weixian Xue, Chunyao Dong, Ruizhuo Ouyang, Yuqing Miao","doi":"10.1016/j.colsurfb.2025.114992","DOIUrl":null,"url":null,"abstract":"<p><p>With the rapid development of nanomedicine, nanomaterials (NMs) have been used in clinical medicine to improve treatment efficiency. Bismuth-based nanomaterials(BNMs) are promising candidates for cancer diagnosis and therapy because of their good biocompatibility, low cost, high X-ray attenuation and near infrared absorption coefficient. The traditional therapy mode is relatively single, and the treatment effect is not significantly improved. Therefore, the combination of traditional treatment and emerging treatment not only has high lethality to tumor cell, but also makes up for their shortcomings. This review summarizes the latest research on BNMs in tumor therapy in recent years, including: the design and preparation of BNMs, the synergy of multiple treatment technologies, and the biosafety of nanomaterials. In the end, the inspiration and reference for the study of Bi-based multifunctional nano-platforms were provided for clinical use.</p>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"256 Pt 1","pages":"114992"},"PeriodicalIF":5.6000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colloids and Surfaces B: Biointerfaces","FirstCategoryId":"1","ListUrlMain":"https://doi.org/10.1016/j.colsurfb.2025.114992","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0

Abstract

With the rapid development of nanomedicine, nanomaterials (NMs) have been used in clinical medicine to improve treatment efficiency. Bismuth-based nanomaterials(BNMs) are promising candidates for cancer diagnosis and therapy because of their good biocompatibility, low cost, high X-ray attenuation and near infrared absorption coefficient. The traditional therapy mode is relatively single, and the treatment effect is not significantly improved. Therefore, the combination of traditional treatment and emerging treatment not only has high lethality to tumor cell, but also makes up for their shortcomings. This review summarizes the latest research on BNMs in tumor therapy in recent years, including: the design and preparation of BNMs, the synergy of multiple treatment technologies, and the biosafety of nanomaterials. In the end, the inspiration and reference for the study of Bi-based multifunctional nano-platforms were provided for clinical use.

铋基纳米材料:设计、合成及其在肿瘤协同治疗中的应用。
随着纳米医学的快速发展,纳米材料已被广泛应用于临床医学,以提高治疗效率。铋基纳米材料具有良好的生物相容性、低成本、高x射线衰减和近红外吸收系数等优点,在癌症诊断和治疗中具有广阔的应用前景。传统的治疗模式比较单一,治疗效果没有明显提高。因此,传统治疗与新兴治疗相结合,不仅对肿瘤细胞具有较高的致死率,而且弥补了各自的不足。本文综述了近年来生物纳米材料在肿瘤治疗中的最新研究进展,包括生物纳米材料的设计与制备、多种治疗技术的协同作用、纳米材料的生物安全性等。最后,为bi基多功能纳米平台的研究提供了启示和参考。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Colloids and Surfaces B: Biointerfaces
Colloids and Surfaces B: Biointerfaces 生物-材料科学:生物材料
CiteScore
11.10
自引率
3.40%
发文量
730
审稿时长
42 days
期刊介绍: Colloids and Surfaces B: Biointerfaces is an international journal devoted to fundamental and applied research on colloid and interfacial phenomena in relation to systems of biological origin, having particular relevance to the medical, pharmaceutical, biotechnological, food and cosmetic fields. Submissions that: (1) deal solely with biological phenomena and do not describe the physico-chemical or colloid-chemical background and/or mechanism of the phenomena, and (2) deal solely with colloid/interfacial phenomena and do not have appropriate biological content or relevance, are outside the scope of the journal and will not be considered for publication. The journal publishes regular research papers, reviews, short communications and invited perspective articles, called BioInterface Perspectives. The BioInterface Perspective provide researchers the opportunity to review their own work, as well as provide insight into the work of others that inspired and influenced the author. Regular articles should have a maximum total length of 6,000 words. In addition, a (combined) maximum of 8 normal-sized figures and/or tables is allowed (so for instance 3 tables and 5 figures). For multiple-panel figures each set of two panels equates to one figure. Short communications should not exceed half of the above. It is required to give on the article cover page a short statistical summary of the article listing the total number of words and tables/figures.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信